Clonidine hydrochloride
Brand names: Catapres, Dixarit
Clonidine hydrochloride is a centrally acting antihypertensive, also used in some settings for resistant hypertension and certain off-licence indications such as menopausal flushing.
ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.
Clinical monograph
How it works
It stimulates central alpha-2 adrenoceptors, reducing sympathetic outflow from the brain to lower peripheral vascular resistance, heart rate and blood pressure.
Prescribing in practice
- Do not stop abruptly, as sudden withdrawal can cause a dangerous rebound hypertensive crisis, so always taper the dose.
- Sedation, dry mouth and a slow heart rate are common, and it should be used cautiously with other sedating or rate-limiting drugs.
- Use caution in bradyarrhythmias and significant cerebrovascular or cardiovascular disease.
Monitoring
Monitor blood pressure and heart rate, with particular vigilance for rebound hypertension if treatment is interrupted.
Counselling the patient
- Never stop this medicine suddenly; reductions must be gradual and supervised.
- It may cause drowsiness and a dry mouth, so take care with driving until you know how it affects you.
- Report fainting, a very slow pulse or a sudden rise in blood pressure if a dose is missed.
Evidence & guidelines
The rebound hypertension risk on abrupt withdrawal of centrally acting alpha-2 agonists is well established, and clonidine remains a recognised option for resistant hypertension in current prescribing references.
Reference: Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).
Related
Curated clinical cross-links plus same-class fallbacks.
- Acute Heart Failure · ESC 2021 Heart Failure Guidelines; NICE NG106
- NSTEMI / Unstable Angina · ESC 2020 NSTEMI Guidelines; NICE NG185
- New-Onset Atrial Fibrillation · ESC 2020 AF Guidelines; NICE NG196
- Hypertensive Emergency · ESC/ESH 2018 Hypertension Guidelines; NICE NG136
- Bradycardia Management · Resuscitation Council UK ABCDE; ESC 2021 Pacing Guidelines
- Ventricular Tachycardia / Fibrillation · Resuscitation Council UK ACLS; ESC 2022 Ventricular Arrhythmia Guidelines